Raltegravir potassi
Ended Awarded
- Contract number
- SPE2DP25F061L
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $4,089
Award facts
- Contract value 100% obligated
- $4,088.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award valued at $4,088.79 for Raltegravir Potassium from the Defense Logistics Agency's Medical Supply Chain on August 13, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 25, 2025, represents a specific pharmaceutical product fulfillment under the company's broader federal supply relationship. The award includes no set-aside designation, allowing the vendor to compete on its merits within the open federal market.
This delivery order is issued under DMS Pharmaceutical Group's substantial Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. The IDC, established under the SPE2DB program, enables the agency to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables supporting Department of Defense healthcare facilities worldwide. As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group fulfills direct distribution requirements for prescription medications and pharmacy services to military health facilities, with Raltegravir Potassium representing one of numerous pharmaceutical line items delivered under this indefinite quantity arrangement.
Quick answers
Who was awarded contract SPE2DP25F061L?
SPE2DP25F061L was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 13, 2025.
How much is contract SPE2DP25F061L worth?
The government has obligated $4,089 on SPE2DP25F061L.
Is contract SPE2DP25F061L an order under another contract?
Yes. SPE2DP25F061L is a delivery order under SPE2DX15D9383, an indefinite delivery contract.
Was contract SPE2DP25F061L competed?
The extent of competition for SPE2DP25F061L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award